7. Fasinu P, Choonara Y, Khan R, Du Toit L C, Kumar P, Ndesendo V, Pillay V. Flavonoids and Polymer Derivatives as CYP3A4 Inhibitors for Improved Oral Drug Bioavailability. J Pharm Sci . 2013 Feb;102(2):541-55. https://www.semanticscholar.org/paper/Flavonoids-and-polymer-derivatives-as-CYP3A4-for-Fasinu-Choonara/f864b48f29cc8abe610cc8f7b6300202ad4d4300
*These statements have not been evaluated by the FDA. This product is not intended to treat, diagnose, or cure any disease. Consult your personal medical professional before use.
1. https://journals.sagepub.com/doi/abs/10.1177/17151635221089617#.YmGO0n9SUBk.linkedin
2. Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819335/pdf/42238_2020_Article_16.pdf
3. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study https://pubmed.ncbi.nlm.nih.gov/27573936/
1. Opiate reduction with cannabis 2017 by Dr. Burchman https://journals.sagepub.com/doi/abs/10.1177/0269881117699616
2. Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823130/
Copyright © 2022 CBD Philman - All Rights Reserved.
"Be Excellent To Each Other."
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.